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The efficacy of app-supported smartphone interventions for mental 
health problems: a meta-analysis of randomized controlled trials
Jake Linardon1, Pim Cuijpers2, Per Carlbring3, Mariel Messer1, Matthew Fuller-Tyszkiewicz1,4
1School of Psychology, Deakin University, Geelong, Victoria, Australia; 2Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research In-
stitute,  Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 3Department of Psychology, Stockholm University, Stockholm, Sweden; 4Center for Social and Early Emo-
tional Development, Deakin University, Burwood, Victoria, Australia
Although impressive progress has been made toward developing empirically-supported psychological treatments, the reality remains that a signif-
icant proportion of people with mental health problems do not receive these treatments. Finding ways to reduce this treatment gap is crucial. 
Since app-supported smartphone interventions are touted as a possible solution, access to up-to-date guidance around the evidence base and 
clinical utility of these interventions is needed. We conducted a meta-analysis of 66 randomized controlled trials of app-supported smartphone 
interventions for mental health problems. Smartphone interventions significantly outperformed control conditions in improving depressive 
(g=0.28, n=54) and generalized anxiety (g=0.30, n=39) symptoms, stress levels (g=0.35, n=27), quality of life (g=0.35, n=43), general psychiat-
ric distress (g=0.40, n=12), social anxiety symptoms (g=0.58, n=6), and positive affect (g=0.44, n=6), with most effects being robust even after 
adjusting for various possible biasing factors (type of control condition, risk of bias rating). Smartphone interventions conferred no significant 
benefit over control conditions on panic symptoms (g=–0.05, n=3), post-traumatic stress symptoms (g=0.18, n=4), and negative affect (g=–0.08, 
n=5). Studies that delivered a cognitive behavior therapy (CBT)-based app and offered professional guidance and reminders to engage produced 
larger effects on multiple outcomes. Smartphone interventions did not differ significantly from active interventions (face-to-face, computerized 
treatment), although the number of studies was low (n≤13). The efficacy of app-supported smartphone interventions for common mental health 
problems was thus confirmed. Although mental health apps are not intended to replace professional clinical services, the present findings high-
light the potential of apps to serve as a cost-effective, easily accessible, and low intensity intervention for those who cannot receive standard psy-
chological treatment.
Key words: App-supported smartphone interventions, mental health problems, depression, anxiety, general psychiatric distress, positive affect, 
psychological treatments
(World Psychiatry 2019;18:325–336)
The treatment of mental health problems is expected to 
change considerably over the next few decades as a result of the 
widespread availability of Internet and mobile-device applica-
tions, and their use to deliver psychological interventions1,2. 
This change is predicted to alleviate many barriers that stand 
in the way of people seeking or receiving treatment under the 
current model of health care delivery (e.g., insufficient number 
of trained professionals, geographical constraints, lack of ano-
nymity), thereby vastly increasing the availability of psychologi-
cal therapies3,4.
Smartphone interventions, in particular, offer many advan-
tages over other digital interventions (e.g., computer-based), 
including their ability to allow users to engage in exercises 
and monitor symptoms in situ, in real time, and immediately 
before and after pivotal events, as well as their capacity to be 
accessed in private and at a time and location of choice5. How-
ever, some have noted possible risks with app-based smart-
phone interventions, a crucial one being the ease with which 
users may have access to potentially ineffective or harmful 
interventions6. Thus, practitioners and the general population 
need up-to-date guidance on the evidence base and clinical 
utility of app-supported smartphone interventions.
The efficacy of smartphone interventions for common and 
costly mental health problems, such as depressive and anxiety 
symptoms, was preliminarily documented in two recent meta-
analyses. Firth et al7,8 identified a small number of randomized 
controlled trials (RCTs) that examined the efficacy of app-based 
smartphone interventions on symptoms of anxiety (n=9) and 
depression (n=18) in both clinical and non-clinical samples. 
Smartphone interventions were found to be significantly more 
efficacious in reducing symptoms of anxiety and depression 
than both waitlist (g=0.45 and g=0.56) and active control (mainly 
attention/placebo-based) groups (g=0.19 and g=0.21). The au-
thors found no evidence that various intervention features (e.g., 
in-app feedback, mood monitoring features, theoretical orien-
tation) were significantly associated with effect sizes, although 
larger effects were observed when in-person feedback was not 
provided7. Preliminary findings from these meta-analyses sug-
gest that app-supported smartphone interventions have poten-
tial in treating and preventing certain common and debilitating 
mental health problems.
Since the publication of those two meta-analyses, which in-
cluded data from RCTs published until May 2017, nearly 50 RCTs 
evaluating the efficacy of smartphone apps on various mental 
health outcomes have been conducted. Since most RCTs of 
smartphone apps have been published within the last couple 
of years, and interventions delivered through smartphone de-
vices are attracting enormous public, scientific and media atten-
tion9, we expect that a significant number of additional RCTs will 
be conducted and published in the near future.
It is therefore timely, pertinent and necessary to conduct 
an updated meta-analysis examining the efficacy of app-sup-
ported smartphone interventions not only on symptoms of 
anxiety and depression, but also on other prevalent, costly and 
important mental health outcomes not examined in prior me-
ta-analyses, including stress levels, specific anxiety symptoms 
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(e.g., social anxiety, post-traumatic stress) and well-being/
quality of life.
The aims of the present meta-analysis of RCTs were to evalu-
ate the efficacy of app-supported smartphone interventions on 
a range of mental health outcomes, and to examine whether 
various features related to the intervention (theoretical orien-
tation, whether professional guidance was offered, whether 
reminders to engage were sent) and sample (degree of mental 
health problem) moderated the observed effect sizes.
METHODS
Search strategy and study selection
We searched four major online databases (Medline, Psyc-
INFO, Cochrane databases, Web of Science) in December 2018, 
using the search terms (“smartphone*” OR “mobile phone” 
OR “cell phone” OR “mobile app*” OR “iphone” OR “android” 
OR “mhealth” OR “m-health” OR “cellular phone” OR “mo-
bile device*” OR “mobile-based” OR "mobile health" OR “tab-
let-based”) AND (“random*” OR “trial*” OR “allocat*”) AND 
(“anxiety” OR “agoraphobia” OR “phobia*” OR “panic” OR 
“post-traumatic stress” OR “mental health” OR “mental illness*” 
OR “depress*” OR “affective disorder*” OR “bipolar” OR “mood 
disorder*” OR “psychosis” OR “psychotic” OR “schizophre*” OR 
“well-being” OR “wellbeing” OR “quality of life” OR “self-harm” 
or “self-injury” OR “stress*” OR “distress*” OR “mood” OR “body 
image” OR “eating disorder*”). Reference lists of included stud-
ies and previous reviews were also hand-searched to identify 
any further eligible studies.
A protocol for this review was registered via PROSPERO 
(CRD42019122136). There were three small deviations to the 
original protocol. First, we made a post-hoc decision to include 
rather than exclude studies that incorporated an app-supported 
smartphone intervention within a broader treatment program 
(e.g., additive or adjunctive designs). Second, we did not con-
duct meta-analyses of head-to-head comparisons of CBT vs. 
non-CBT-based apps, as there was an insufficient number of 
relevant studies. Third, we included an additional moderator, 
i.e. whether the smartphone intervention was directly aimed at 
targeting the specific symptom of interest.
Included studies were English language RCTs that examined 
the effects of an app-supported smartphone intervention, com-
pared to either a control condition or an active intervention, and 
provided the outcome data required to calculate an effect size.
Both published and unpublished RCTs were eligible for in-
clusion. Provided the smartphone intervention was designed 
Figure 1 PRISMA flow chart of literature search. RCT – randomized controlled trial
 Records identied through database 
searching  
(N=3,761) 
Additional unpublished records 
identied through other sources 
(N=2) 










Full-text articles excluded (N=73) 
•
Not an intervention delivered via
smartphone device (N=31)
•




No relevant outcome measure (N=12)
•
No relevant comparison (N=10)
•




Secondary analyses from RCT (N=1)
•
Single session intervention (N=1)
No data to calculate effect size (N=4)
Studies included in meta-
analysis 
(N=66) 
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Table 1 Meta-analysis of  efficacy of  mental health smartphone apps on depressive and generalized anxiety symptoms
Depressive symptoms Generalized anxiety symptoms
N g (95% CI) I2 (95% CI) Q N g (95% CI) I2 (95% CI) Q
Smartphone vs. controls
 Overall effect 54 0.28 (0.21-0.36)*** 54% (38-66) 39 0.30 (0.20-0.40)*** 63% (48-73)
 Adjusted for publication bias 37 0.41 (0.32-0.49) 31 0.39 (0.28-0.49)
Sensitivity analysis
 One effect size per study (smallest) 41 0.28 (0.18-0.37)*** 58% (40-70) 28 0.31 (0.18-0.43)*** 69% (54-78)
 One effect size per study (largest) 41 0.37 (0.29-0.44)*** 41% (15-59) 28 0.38 (0.27-0.49)*** 64% (46-75)
 Low risk of  bias only (all criteria met) 13 0.43 (0.31-0.55)*** 41% (0-68) 7 0.56 (0.39-0.74)*** 56% (5-80)
Control condition type
 Waitlist 34 0.32 (0.22-0.42)*** 52% (28-67) 28 0.32 (0.19-0.44)*** 63% (45-75)
 Informational resources 8 0.39 (0.21-0.58)*** 60% (17-80) 3 0.51 (0.14-0.88)** 72% (17-90)
 Attentional/placebo control 11 0.12 (0.01-0.23)* 6% (0-31) 8 0.18 (0.07-0.29)** 7% (0-20)
Subgroup analyses
 Target sample 0.151 0.358
  Elevated symptoms entry criteria 13 0.38 (0.23-0.52)*** 61% (30-78) 10 0.36 (0.25-0.47)*** 0% (0-58)
  Elevated symptoms not entry criteria 41 0.24 (0.16-0.33)*** 50% (28-64) 29 0.28 (0.15-0.41)*** 70% (57-79)
 Smartphone intervention target 0.728 0.319
  Directly aimed at targeting this outcome 16 0.26 (0.11-0.41)*** 71% (52-82) 12 0.24 (0.09-0.38)** 44% (0-69)
  Not directly aimed at targeting this outcome 38 0.29 (0.21-0.38)*** 43% (16-61) 27 0.33 (0.21-0.46)*** 68% (53-78)
 CBT-based app 0.125 0.011
  Yes 26 0.34 (0.23-0.46)*** 64% (46-76) 16 0.42 (0.26-0.57)*** 76% (57-100)
  No 27 0.23 (0.14-0.32)*** 22% (0-50) 23 0.19 (0.11-0.27)*** 0% (0-43)
 Contains mindfulness components 0.359 0.952
  Yes 28 0.33 (0.24-0.41)*** 24% (0-50) 24 0.30 (0.20-0.41)*** 43% (8-64)
  No 25 0.25 (0.12-0.39)*** 68% (51-78) 15 0.29 (0.10-0.49)** 77% (63-86)
 ACT-based app 0.903 0.967
  Yes 9 0.30 (0.08-0.53)** 33% (0-66) 8 0.30 (0.11-0.49)** 1% (0-10)
  No 44 0.28 (0.20-0.37)*** 57% (39-68) 31 0.30 (0.19-0.41)*** 69% (55-78)
 Reminders to engage provided 0.065 0.004
  Yes 34 0.32 (0.22-0.42)*** 61% (43-72) 23 0.39 (0.27-0.52)*** 63% (42-76)
  No 20 0.18 (0.08-0.29)** 16% (0-45) 16 0.15 (0.04-0.26)* 18% (0-50)
 Professional guidance provided 0.002 0.001
  Yes 15 0.48 (0.34-0.62)*** 46% (4-69) 12 0.53 (0.36-0.70)*** 60% (26-78)
  No 37 0.23 (0.15-0.31)*** 32% (0-54) 27 0.21 (0.12-0.30)* 36% (0-59)
 Duration of  post-assessment <0.001 <0.001
  2-6 weeks 33 0.17 (0.08-0.26)*** 30% (0-53) 24 0.11 (0.02-0.21)* 12% (0-41)
  7-11 weeks 18 0.46 (0.36-0.55)*** 45% (3-66) 15 0.52 (0.41-0.63)*** 44% (0-68)
  12+ weeks 3 0.09 (–0.23 to 0.42) 49% (0-80) 0 -
Apps vs. active comparison
 Overall effect 12 0.13 (–0.07 to 0.34) 60% (27-78) 4 0.09 (–0.21 to 0.39) 32% (0-68)
 Low risk of  bias trials only 4 –0.00 (–0.36 to 0.35) 77% (41-90) 0 - -
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Depressive symptoms Generalized anxiety symptoms
N g (95% CI) I2 (95% CI) Q N g (95% CI) I2 (95% CI) Q
Smartphones as an adjunct intervention 4 0.26 (–0.09 to 0.61) 71% (26-89) 1 0.05 (–0.27 to 0.38) 0%
N – number of  comparisons, CBT– cognitive behavior therapy, ACT – acceptance and commitment therapy
*p<0.05, **p<0.01, ***p<0.001. Bold prints indicate significant differences
Table 1 Meta-analysis of  efficacy of  mental health smartphone apps on depressive and generalized anxiety symptoms (continued)
to improve mental health or general well-being, no restrictions 
on the samples were applied. Trials of interventions delivered 
only in part via smartphone devices were also included, such 
as adjunctive designs (smartphone app + standard therapy 
vs. standard therapy alone) or blended intervention programs 
(when participants could access the app-based intervention via 
smartphones or computers).
Control conditions were categorized as waitlist, assessment 
only, treatment as usual, informational and educational re-
sources (e.g., website links, health tips), or attention/placebo 
controls (e.g., gaming apps, music-listening conditions). Active 
interventions were categorized as standard face-to-face therapy, 
web-based or computerized interventions, pharmacotherapy, 
and self-monitoring conditions.
Studies were excluded if: a) the smartphone intervention did 
not address mental health or well-being (e.g., interventions fo-
cusing on weight loss, physical activity, diabetes management, 
smoking cessation or alcohol use were excluded); b) a comput-
erized intervention, a virtual reality exposure treatment, or a text 
messaging-only intervention was delivered; and c) there was no 
relevant comparison condition (e.g., a two-arm trial comparing 
two apps was excluded) or no outcome measure was reported. 
If a study did not include data for effect size calculation, the au-
thors were contacted, and the study was excluded if they failed 
to provide the data.
JL screened all records, and full texts were obtained for po-
tentially eligible RCTs. Two independent assessors (JL and MM) 
examined the full texts and selected eligible RCTs.
Quality assessment and data extraction
The quality of trials was assessed using four criteria from the 
Cochrane Risk of Bias tool10: adequate generation of allocation 
sequence, concealment of allocation to conditions; blinding of 
outcome assessors or the use of self-report questionnaires; and 
dealing with incomplete outcome data (assessed as low risk 
when outcome data used to calculate effect size were based on 
intention-to-treat analyses). JL conducted the quality assess-
ments and MM coded a random 40% of studies, with good agree-
ment observed between raters (kappa = 0.77, 0.69, 1.00 and 0.91, 
respectively). Disagreements were resolved through in-depth 
discussion.
We also coded the participant characteristics (target sam-
ple, mean age); the characteristics of the smartphone interven-
tion (name, theoretical orientation, whether the app contained 
mindfulness components); the comparison condition; the out-
come measures; and other trial characteristics (sample size, 
whether guided support or reminders to engage were offered, 
length of post-assessment).
Meta-analysis
For each comparison between a smartphone intervention 
and a control or active intervention condition, the effect size 
was calculated by dividing the difference between the two group 
means by the pooled standard deviation at post-test. The stan-
dardized mean difference (d) was then converted to Hedges’ g 
to correct for small sample bias11. If means and standard devia-
tions were not reported, effect sizes were calculated using con-
version equations from significance tests (e.g., t statistics).
To calculate a pooled effect size, each study’s effect size was 
weighted by its inverse variance. A positive g indicates that the 
smartphone condition had better outcomes than the compar-
ison condition. Effect sizes of 0.8 can be assumed to be large, 
while effect sizes of 0.5 are moderate, and effect sizes of 0.2 are 
small12. If data from both intention-to-treat and completer anal-
yses were presented, the former were extracted and analyzed.
We selected and analyzed the following mental health out-
comes, as a sufficient number of trials (≥3) reported these out-
comes and allowed for a meta-analysis: depressive symptoms; 
generalized anxiety symptoms; specific anxiety symptoms (so-
cial anxiety symptoms, panic symptoms, post-traumatic stress 
symptoms); stress levels; quality of life/well-being; general psy-
chological distress; and positive and negative affect. If multiple 
measures of a given outcome variable were used, the mean of 
the effect sizes from each measure within the study was calcu-
lated, before the effect sizes were pooled.
Comprehensive Meta-Analysis Version 3.0 was used for the 
analyses13. Since we expected considerable heterogeneity 
among the studies, random effects models were employed. Het-
erogeneity was examined by calculating the I2 statistic, which 
quantifies heterogeneity revealed by the Q statistic and reports 
how much overall variance (0-100%) is attributed to between-
study variance14. The 95% confidence intervals (CIs) for the I2 
statistic were also calculated.
Subgroup analyses were conducted to explore sources of 
 het erogeneity under a mixed effects model, which pools stud-
ies within a subgroup using a random effects model, but tests 
for significant differences between subgroups using fixed effects 
models.
Publication bias was examined through the trim-and-fill pro-
cedure15, as well as Begg and Mazumdar rank correlation test.
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Figure 2 Effect of smartphone apps vs. control conditions on depressive symptoms
Study Statistics for each study
Hedges’ g Variance p
Bakker et al16 -0.213 0.026 0.183
Teng et al17 -0.195 0.077 0.481
Krafft et al18 -0.182 0.175 0.663
Bakker et al16 -0.130 0.025 0.414
Versluis et al19 -0.117 0.055 0.618
Kauer et al20 -0.108 0.049 0.627
Teng et al17 -0.088 0.063 0.725
Krzystanek et al21 -0.085 0.030 0.623
Krafft et al18 -0.077 0.150 0.841
Faurholt-Jepsen et al22 -0.045 0.058 0.852
Enock et al23 -0.042 0.013 0.714
Krafft et al18 -0.039 0.096 0.899
Oh et al24 0.057 0.113 0.864
Ivanova et al25 0.071 0.039 0.716
Dennis-Tiwary et al26 0.073 0.131 0.839
Versluis et al19 0.078 0.058 0.745
Ludtke et al27 0.083 0.053 0.718
Arean et al28 0.110 0.098 0.725
Carissoli et al29 0.126 0.101 0.691
Krafft et al18 0.137 0.087 0.641
Flett et al30 0.171 0.029 0.317
Mistretta et al31 0.195 0.106 0.550
Birney et al32 0.197 0.013 0.087
Hirsch et al33 0.204 0.050 0.360
Oh et al24 0.207 0.111 0.533
Bakker et al16 0.225 0.026 0.159
Kuhn et al34 0.228 0.033 0.211
Flett et al30 0.228 0.027 0.168
Lee & Jung35 0.229 0.025 0.143
Moell et al36 0.230 0.074 0.397
Guo et al37 0.233 0.074 0.392
Boettcher et al38 0.296 0.029 0.081
Stolz et al5 0.297 0.049 0.180
Cox et al39 0.315 0.097 0.312
Roepke et al40 0.318 0.077 0.250
Proudfoot et al41 0.332 0.013 0.004
Howells et al42 0.347 0.033 0.057
Kollei et al43 0.390 0.075 0.153
Arean et al28 0.417 0.010 0.000
Kahn et al44 0.437 0.046 0.041
Proudfoot et al41 0.446 0.013 0.000
Bostock et al45 0.470 0.019 0.001
Ebert et al46 0.528 0.020 0.000
Ebert et al47 0.547 0.016 0.000
Horsch et al48 0.571 0.027 0.001
Ivanova et al25 0.580 0.041 0.004
Ebert et al49 0.594 0.016 0.000
Enock et al23 0.608 0.044 0.004
Harrer et al50 0.625 0.028 0.000
Heber et al51 0.639 0.016 0.000
Tighe et al52 0.707 0.068 0.007
Roepke et al40 0.777 0.087 0.008
Hall et al53 0.831 0.112 0.013
Nobis et al54 0.855 0.017 0.000
Total pooled effect size 0.282 0.002 0.000
Hedges’ g and 95% CI
Favours control Favours app
-2.00 -1.00 0.00 1.00 2.00
RESULTS
Characteristics of included studies
A flow chart of the literature search is presented in Figure 1. 
Out of a total of 3,136 screened abstracts, 66 RCTs with 77 smart-
phone intervention conditions were included. A variety of smart-
phone apps were tested, most of which were based on cogni-
tive and/or behavioral principles (n=35) and/or acceptance- or 
mindfulness-based principles (n=38).
Numerous trials used some indication of mental health prob-
lems as an inclusion criterion for study entry (n=38), which most 
frequently included those presenting with elevated levels (either 
at a diagnostic or subthreshold level) of depression (n=14), anxi-
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Figure 3 Effect of smartphone apps vs. control conditions on generalized anxiety symptoms
Study Statistics for each study
Hedges’ g Variance p
Dennis-Tiwary et al26 -0.305 0.132 0.401
Bakker et al16 -0.234 0.026 0.144
Teng et al17 -0.203 0.077 0.465
Krafft et al18 -0.187 0.096 0.548
Bakker et al16 -0.140 0.025 0.380
Mistretta et al31 -0.087 0.106 0.789
Krafft et al18 -0.020 0.096 0.950
Krafft et al18 0.000 0.175 1.000
Flett et al30 0.018 0.029 0.914
Pham et al55 0.028 0.062 0.912
Versluis et al19 0.047 0.055 0.843
Flett et al30 0.081 0.027 0.625
Carissoli et al29 0.126 0.101 0.691
Villani et al56 0.152 0.006 0.050
Cox et al39 0.177 0.096 0.569
Bakker et al16 0.179 0.025 0.263
Oh et al24 0.182 0.113 0.588
Ebert et al46 0.219 0.020 0.117
Moell et al36 0.239 0.074 0.380
Ivanova et al25 0.273 0.039 0.167
Versluis et al19 0.277 0.058 0.250
Roepke et al40 0.291 0.076 0.292
Lee & Jung35 0.294 0.025 0.061
Oh et al24 0.364 0.112 0.276
Proudfoot et al41 0.365 0.013 0.001
Bostock et al45 0.377 0.019 0.006
Proudfoot et al41 0.435 0.013 0.000
Boettcher et al38 0.459 0.029 0.007
Teng et al17 0.478 0.065 0.060
Ebert et al47 0.505 0.016 0.000
Ivanova et al25 0.512 0.040 0.011
Roepke et al40 0.575 0.084 0.047
Horsch et al48 0.647 0.028 0.000
Heber et al51 0.677 0.016 0.000
Krafft et al18 0.706 0.159 0.077
Harrer et al50 0.757 0.028 0.000
Ebert et al49 0.792 0.016 0.000
Nobis et al54 0.819 0.017 0.000
Hall et al53 0.843 0.112 0.012
Total pooled effect size 0.304 0.003 0.000
Hedges’ g and 95% CI
Favours control Favours app
-2.00 -1.00 0.00 1.00 2.00
ety (n=9), or stress (n=8). Several trials (n=28) did not use any 
indication of mental health problems as an inclusion criterion 
(e.g., general community sample, student samples), but rather 
targeted general well-being in these samples.
The quality of RCTs varied. Fifty trials (75.7%) reported an ade-
quate sequence generation; 24 (36.4%) used adequate allocation 
concealment; four (6.1%) reported blinding of outcome asses-
sors and 62 (93.9%) used self-report questionnaires (so that direct 
interaction with an assessor was not required); and 37 studies 
(56.1%) reported data needed to calculate an effect size based 
on the intention-to-treat principle. Seventeen trials (25.7%) met 
all four criteria, 16 (24.2%) met three criteria, 27 (40.9%) met two 
criteria, and six trials (9.1%) met one of the criteria.
Efficacy of smartphone interventions on depressive 
symptoms
Smartphone interventions vs. controls
Depressive symptoms were assessed as an outcome in 47 tri-
als (71.2%), and 11 trials (16 comparisons) delivered an app that 
was specifically designed to target depressive symptoms.
The pooled effect size for the 54 comparisons between smart-
phone interventions and control conditions on depressive 
symptoms was g=0.28 (95% CI: 0.21-0.36), with moderate het-
erogeneity (see Table 1 and Figure 2). The pooled effect size was 
somewhat larger when adjusting for potential publication bias 
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Table 2 Efficacy of  mental health smartphone apps on stress levels and quality of  life outcomes
Stress levels Quality of life
N g (95% CI) I2 (95% CI) Q N g (95% CI) I2 (95% CI) Q
Smartphone vs. control conditions
 Overall effect 27 0.35 (0.21-0.48)*** 69% (55-79) 43 0.35 (0.29-0.42)*** 24% (0-47)
 Adjusted for publication bias 22 0.44 (0.30-0.57) - 37 0.39 (0.32-0.46)
Sensitivity analysis
 One effect size per study (smallest) 22 0.38 (0.22-0.54)*** 72% (58-82) 34 0.36 (0.29-0.44)*** 29% (0-53)
 One effect size per study (largest) 22 0.42 (0.28-0.57)*** 65% (46-77) 34 0.41 (0.35-0.47)*** 0% (0-36)
 Low risk of  bias only 4 0.78 (0.63-0.04)*** 0% (0-22) 10 0.46 (0.31-0.61)*** 50% (1-74)
Control type
 Waitlist 20 0.47 (0.33-0.62)*** 60% (36-75) 37 0.35 (0.28-0.43)*** 29% (0-52)
 Informational sources 1 0.06 (–0.32 to 0.44) 0 4 0.41 (0.21-0.61)*** 0% (0-84)
 Attentional/placebo control 6 0.09 (–0.05 to 0.24) 0% (0-74) 2 0.23 (0.03-0.42)* 0%
Subgroup analyses
 Target sample 0.010 0.084
  Clinical sample - - - 6 0.24 (0.07-0.41)** 0% (0-57)
  Symptomatic/at-risk sample 7 0.59 (0.35-0.83)*** 80% (61-90) 12 0.44 (0.33-0.56)*** 45% (0-70)
  Non-clinical/non-symptomatic sample 20 0.24 (0.09-0.37)** 45% (9-67) 25 0.31 (0.23-0.39)*** 4% (0-46)
 CBT-based app 0.003 0.823
  Yes 8 0.61 (0.39-0.83)*** 77% (56-88) 19 0.37 (0.26-0.48)*** 45% (8-67)
  No 19 0.21 (0.07-0.35)** 45% (7-67) 23 0.35 (0.27-0.44)*** 0% (0-39)
 Contains mindfulness components 0.371 0.968
  Yes 23 0.31 (0.19-0.44)*** 58% (33-73) 29 0.36 (0.29-0.43)*** 7% (0-33)
  No 4 0.52 (0.09-0.95)* 80% (52-92) 13 0.36 (0.22-0.49)*** 48% (4-71)
 ACT-based app 0.252 0.305
  Yes 5 0.16 (–0.17 to 0.49) 30% (0-66) 13 0.29 (0.13-0.44)*** 15% (0-62)
  No 22 0.38 (0.23-0.52)*** 72% (58-82) 29 0.38 (0.31-0.45)*** 25% (0-51)
 Reminders to engage provided 0.066 0.025
  Yes 20 0.41 (0.25-0.57)*** 73% (57-82) 29 0.39 (0.32-0.47)*** 28% (0-53)
  No 7 0.19 (0.03-0.35)* 1% (0-71) 14 0.24 (0.14-0.35)*** 0% (0-41)
 Professional guidance provided 0.010 0.001
  Yes 10 0.57 (0.35-0.79)*** 63% (29-80) 13 0.52 (0.39-0.64)*** 24% (0-57)
  No 17 0.24 (0.12-0.36)*** 42% (0-66) 30 0.29 (0.22-0.35)*** 0% (0-21)
 Duration of  post-assessment <0.001 0.971
  2-6 weeks 19 0.18 (0.06-0.28)** 13% (0-44) 31 0.35 (0.26-0.44)*** 30% (0-54)
  7-11 weeks 6 0.63 (0.38-0.88)*** 83% (65-91) 11 0.36 (0.26-0.46)*** 17% (0-51)
  12+ weeks 2 0.59 (0.35-0.83)*** 20% (0-33) 1 0.31 (–0.13 to 0.74) 0%
Apps vs. active comparisons
 Overall effect 2 0.21 (–0.46 to 0.88) 72% (27-88) 6 0.02 (–0.14 to 0.17) 0% (0-57)
 Low risk of  bias trials only - - - 3 –0.08 (–0.27 to 0.12) 0% (0-66)
N – number of  comparisons, CBT– cognitive behavior therapy, ACT – acceptance and commitment therapy
*p<0.05, **p<0.01, ***p<0.001. Bold prints indicate significant differences
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(g=0.41, Begg and Mazumdar test: p=0.087) and when analyzing 
only low risk of bias trials (g=0.43).
The pooled effect size was small but still statistically sig-
nificant when attention/placebo control conditions were used 
(g=0.12), and larger when waitlist (g=0.32) or informational re-
sources (g=0.39) were used as control conditions.
In the previous analyses, we included a few trials in which 
more than one intervention condition was compared with the 
same control condition (or vice versa). These comparisons were 
not independent from each other, which may have artificially 
reduced the heterogeneity estimate and affected the pooled ef-
fect size. To deal with this, we ran sensitivity analyses in which 
the comparison with the smallest effect size was only included 
in the analysis, and then repeated this again for the comparison 
with the largest effect size. These sensitivity analyses ensured 
that only one comparison per study was included in the meta-
analysis. These sensitivity analyses yielded a pooled effect size 
highly similar to the overall effect (Table 1).
Subgroup analyses
Subgroup analyses were conducted to test whether various 
participant or trial characteristics were significantly associated 
with the pooled effect size (Table 1).
Studies that offered professional guidance (e.g., regular sup-
portive text messages, phone calls, or personalized feedback 
from therapists or research staff) produced larger effect sizes 
than studies that did not offer guidance. Studies with a follow-up 
length between 7 and 11 weeks produced larger effect sizes than 
studies with a follow-up length of 2-6 or ≥12 weeks. No other 
study characteristics were significantly associated with effect 
sizes.
Smartphone interventions vs. active comparisons
The pooled effect size for the 12 comparisons between smart-
phone interventions and active comparisons was g=0.13 (95% 
CI: –0.07 to 0.34), with moderate heterogeneity. Non-significant 
effect sizes were observed for low risk of bias trials.
Additive effects of smartphone interventions
Four trials examined whether adding a smartphone inter-
vention to a standard intervention (face-to-face, computerized, 
pharmacotherapy) was superior to a standard intervention-only 
condition. The pooled effect size for the four comparisons be-
tween smartphone intervention + standard intervention vs. the 
standard intervention-only arm was g=0.26 (95% CI: –0.09 to 0.61).
Efficacy of smartphone interventions on generalized 
anxiety symptoms
Smartphone interventions vs. controls
Generalized anxiety symptoms were assessed as an outcome 
Table 3 Meta-analysis comparing the effect of  mental health smartphone apps vs. control conditions on other outcomes
Outcome measure Analysis N g (95% CI) I2 (95% CI)
General distress
Overall effect 12 0.40 (0.24-0.56)*** 60% (24-77)
Low risk of  bias trials only 3 0.47 (0.08-0.87)* 70% (15-89)
Social anxiety symptoms
Overall effect 6 0.58 (0.25-0.90)*** 78% (53-89)
Low risk of  bias trials only 3 0.76 (0.51-1.03)*** 0% (0-77)
Panic symptoms
Overall effect 3 –0.05 (–0.41 to 0.31) 0% (0-92)
Low risk of  bias trials only 2 0.12 (–0.41 to 0.65) 0%
Post-traumatic stress symptoms
Overall effect 4 0.18 (–0.04 to 0.41) 0% (0-86)
Low risk of  bias trials only 0 - -
Positive affect
Overall effect 6 0.44 (0.15-0.73)** 67% (24-85)
Low risk of  bias trials only 1 –0.05 (–0.46 to 0.35) 0%
Negative affect
Overall effect 5 –0.08 (–0.48 to 0.32) 76% (45-89)
Low risk of  bias trials only 1 0.26 (–0.14 to 0.67) 0%
*p<0.05; **p<0.01; ***p<0.001
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in 29 studies (43.9%), and eight studies (12 comparisons) deliv-
ered an app that was specifically designed to target generalized 
anxiety symptoms.
The pooled effect size for the 39 comparisons was g=0.30 (95% 
CI: 0.20-0.40), with high heterogeneity (see Table 1 and Figure 3). 
It remained statistically significant across all sensitivity analyses. 
Begg and Mazumdar test was non-significant (p=0.217).
Subgroup analyses
Four statistically significant moderation effects were obser-
ved. Larger effect sizes were found by studies that used a CBT-
based app, that reminded participants to engage in the app, 
that offered professional guidance, and that had a longer post-
assessment duration (7-11 weeks) compared to those with a 
shorter duration (2-6 weeks).
Smartphone interventions vs. active comparisons
The pooled effect size for the four comparisons was g=0.09 
(95% CI: –0.21 to 0.39), with moderate heterogeneity.
Efficacy of smartphone interventions on stress levels
Stress levels were assessed in 22 trials (33.3%). The pooled 
effect size for the 27 comparisons was g=0.35 (95% CI: 0.21-
0.48), with high heterogeneity (Table 2). The pooled effect size 
remained statistically significant across the sensitivity analyses. 
Begg and Mazumdar test was non-significant (p=0.392).
Four significant moderation effects were observed in sub-
group analyses. Larger effect sizes were found by studies that 
used elevated stress levels as an entry criterion for trial inclusion, 
that used a CBT-based app, that offered professional guidance, 
and that had a longer post-assessment duration (≥ 7 weeks) 
compared to those with a shorter duration.
The pooled effect size for the two comparisons of smartphone 
vs. active interventions was g=0.21 (95% CI: –0.46 to 0.88), with 
high heterogeneity.
Efficacy of smartphone interventions on well-being/
quality of life
Measures of well-being/quality of life were assessed in 36 
studies (54.5%). The pooled effect size for the 43 comparisons 
was g=0.35 (95% CI: 0.29-0.42), with low heterogeneity (Table 2). 
The pooled effect size remained statistically significant across all 
sensitivity analyses. Begg and Mazumdar test was non-signifi-
cant (p=0.622).
Two significant moderators were observed in subgroup anal-
yses. Larger effect sizes were found by studies that reminded 
participants to engage, and by those that offered professional 
guidance.
The pooled effect size for the six comparisons of smartphone 
vs. active interventions was g=0.02 (95% CI: –0.14 to 0.17). A neg-
ative, non-significant effect size was observed when restricting 
these analyses to low risk of bias trials.
Efficacy of smartphone interventions on other outcomes
Table 3 presents the meta-analyses comparing smartphone 
interventions to control conditions on “other” outcomes.
Smartphone interventions were significantly more effective 
than control conditions in improving general psychological dis-
tress (g=0.40), social anxiety symptoms (g=0.58), and positive 
affect (g=0.44). No significant group differences were observed 
for panic symptoms (g=–0.05), post-traumatic stress symptoms 
(g=0.18), and negative affect (g=–0.08), although the number of 
studies contributing to these analyses was low.
DISCUSSION
This meta-analysis examined the efficacy of app-supported 
smartphone interventions for a range of mental health problems. 
Our search identified 66 RCTs that tested several smartphone 
interventions on numerous distinct clinical and non-clinical 
populations. Importantly, the majority of RCTs were published 
in the last two years, highlighting that this area of research is 
gaining significant momentum and is growing exponentially.
We found evidence that app-supported smartphone inter-
ventions are efficacious for several common mental health 
problems. They significantly outperformed control conditions 
in improving depressive symptoms, anxiety symptoms (general-
ized anxiety and social anxiety), stress levels, general psychiatric 
distress, quality of life, and positive affect, with effect sizes rang-
ing from g=0.28 to g=0.58. Crucially, these effects were robust 
even after performing various sensitivity analyses that adjusted 
for common biasing factors in RCTs, including the type of con-
trol condition, trial risk of bias rating, and publication bias57,58.
The statistically significant effect sizes were observed in both 
symptomatic (e.g., people meeting diagnostic criteria or report-
ing elevated mental health symptoms) and non-symptomatic 
(e.g., university students, general population) samples, further 
highlighting the potential that smartphone apps could bring 
within current models of mental health care. For instance, smart-
phone interventions could eventually serve as a low-cost, easily 
accessible, and user-friendly option for universal, selective or in-
dicated preventive programs59. Smartphone interventions could 
also fit within the stepped-care model, in which low intensity 
interventions are offered as a first step in treatment, with more 
intensive resources reserved for those who fail to respond60.
Studies that offered professional guidance (e.g., supportive 
text messages, personalized feedback, telephone calls) and en-
gagement reminders were consistently associated with larger 
effect sizes on several mental health outcomes, although smart-
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phone interventions still significantly outperformed control 
conditions even in the subset of studies that did not offer guid-
ance or reminders. That therapist guidance and engagement 
reminders bolster the effectiveness of smartphone interventions 
is consistent with what has been observed in a series of meta-
analyses of Internet-based and computerized psychological 
treatments61-64. However, the involvement of a therapist can be 
costly and may thus restrict the capacity of smartphone apps to 
reach the millions of people around the world in need of (and 
who cannot gain access to) treatment.
It has been suggested that digital interventions may benefit 
from peer or automated support rather than human support 
systems38,65. The development of automated support systems 
may be guided by machine learning principles, so that users 
could receive guidance or prompts that are customized to their 
own needs and in real time66. Automated (and personalized) 
support has been shown to produce equivalent clinical out-
comes to human support in RCTs of computerized treatments67, 
which suggests that developing and testing automated support 
systems for smartphone apps may be an important avenue for 
future research.
We also investigated whether the theoretical orientation of 
the smartphone intervention was associated with effect sizes. 
While interventions containing mindfulness- or acceptance-
based components were not associated with effect sizes, CBT-
based interventions produced larger effects for anxiety and 
stress. However, conclusions concerning the relative efficacy 
of different theoretical orientations would be premature at this 
stage, as too few head-to-head comparisons of different smart-
phone interventions have been performed, and those that com-
pared CBT vs. non-CBT-based smartphone interventions report-
ed no differences in level of symptom improvement68-70.
Smartphone interventions did not significantly differ from 
active interventions on any outcome. These findings, although 
preliminary, are in line with reports regarding Internet-based 
treatments71, and point further toward the clinical utility of 
mental health apps. However, we note that few studies contrib-
uted to these head-to-head comparisons, so these analyses may 
have been underpowered. Power may have also been an issue 
for the other outcomes in which smartphone interventions con-
ferred no benefit over control conditions (panic, post-traumatic 
stress, and negative affect). Alternatively, it could be that the 
content quality of smartphone apps for these specific symptoms 
needs to improve72.
Limitations to the present meta-analysis must be considered. 
First, possible negative effects of smartphone interventions (e.g., 
deterioration rates)73 were not assessed, since they were not re-
ported in the included studies. Future studies should examine 
these possible negative effects74. Second, we did not analyze 
the long-term effects of smartphone interventions, due to large 
differences in follow-up times and since drop-outs were dealt 
with inconsistently across studies. Thus, it is unclear whether 
improvements in mental health are sustained after the period of 
the study. Assessing the long-term efficacy of smartphone inter-
ventions is an important future goal, particularly since promis-
ing long-term effects have been noted in Internet-based trials75. 
Third, nearly all included studies assessed outcomes via self- 
report questionnaires. A previous meta-analysis demonstrated 
that clinician-rated instruments yield significantly larger effect 
sizes in psychotherapy trials than self-reported measures76. So, 
it is possible that our effect size estimates were slightly under-
estimated.
In summary, we found evidence for the efficacy of app-sup-
ported smartphone interventions. They significantly outper-
formed (with small to moderate effect sizes) control conditions 
in improving a range of mental health outcomes, with effects 
remaining robust even after adjusting for various biasing factors 
in RCTs. Studies that offered professional guidance and engage-
ment reminders were shown to produce the largest effects, and 
smartphone interventions did not differ significantly from ac-
tive intervention comparisons on any outcome.
Although mental health apps are not here to replace profes-
sional clinical services, the present findings highlight the poten-
tial of apps to serve as a cost-effective, easily accessible, and low 
intensity intervention for the millions of people worldwide who 
cannot receive standard psychological treatment.
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